Cargando…
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
CD24 and its ligand Siglec-10 were described as an innate immune checkpoint in carcinoma. Here, we investigated this axis in B-cell lymphoma by assessing CD24 expression and evaluating pro-phagocytic effects of CD24 antibody treatment in comparison to hallmark immune checkpoint CD47. In mantle cell...
Autores principales: | Freile, Jimena Álvarez, Ustyanovska Avtenyuk, Natasha, Corrales, Macarena González, Lourens, Harm Jan, Huls, Gerwin, van Meerten, Tom, Cendrowicz, Ewa, Bremer, Edwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138264/ https://www.ncbi.nlm.nih.gov/pubmed/35625912 http://dx.doi.org/10.3390/biomedicines10051175 |
Ejemplares similares
-
Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity
por: Ustyanovska Avtenyuk, Natasha, et al.
Publicado: (2021) -
Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance
por: Choukrani, Ghizlane, et al.
Publicado: (2023) -
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties
por: Vlaming, Martijn, et al.
Publicado: (2021) -
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics
por: Álvarez Freile, Jimena, et al.
Publicado: (2023) -
The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
por: Ustyanovska Avtenyuk, Natasha, et al.
Publicado: (2020)